{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:55:09Z","timestamp":1787849709790,"version":"build-2784847793"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>We present retrospective data from our clinical research efforts of the past several years alongside a review of past and current clinical and preclinical data independently by several investigators supporting our clinical evidence for the importance of inflammation in inherited retinal degenerations (IRDs). We show how inflammation is a complicating factor in IRDs but, if recognized and managed, also a great opportunity to mitigate disease severity immediately, improve patient prognosis and quality of life, extend the treatment windows for gene-specific and agnostic therapeutic approaches, mitigate the impact of inflammatory complications on the accurate estimate of vision changes in IRD natural history studies, improve the chances of safer outcomes following cataract surgery, and potentially reduce the likelihood of inflammatory adverse events and augment the efficacy of viral vector-based treatment approaches to IRDs. Manuscript contribution to the field. Inflammation has been suspected to be at play in IRDs since the beginning of the 1900s and became a research focus through the early 1990s but was then largely abandoned in favor of genetic-focused research. Thanks to regained cognizance, better research tools, and a more holistic approach to IRDs, the recent reappraisal of the role of inflammation in IRDs has brought back to the surface its importance. A potential confounder in natural history studies and a limiting factor in clinical trials if not accounted for, inflammation can be managed and often offers an opportunity for immediately improved prognosis and outcomes for IRD patients. We present our retrospective clinical evidence for connections with a measurable secondary autoimmune component that can develop in IRDs and contribute to vision loss but is at least in part treatable. We also present ample lines of evidence from the literature corroborating our clinical observations at the preclinical level.<\/jats:p>","DOI":"10.3389\/fcell.2023.1177711","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T15:43:35Z","timestamp":1681400615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications"],"prefix":"10.3389","volume":"11","author":[{"given":"Kubra","family":"Sarici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aanal","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1006\/jaut.1998.0239","article-title":"Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: Epitope mapping and cytotoxicity on retinal cells","volume":"11","author":"Adamus","year":"1998","journal-title":"J. Autoimmun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","article-title":"Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies?","volume":"9","author":"Adamus","year":"2018","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12348-011-0028-8","article-title":"Diversity in autoimmunity against retinal, neuronal, and axonal antigens in acquired neuro-retinopathy","volume":"1","author":"Adamus","year":"2011","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17469899.2020.1739522","article-title":"Current techniques to accurately measure anti-retinal autoantibodies","volume":"15","author":"Adamus","year":"2020","journal-title":"Expert Rev. Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"672444","DOI":"10.3389\/fmed.2021.672444","article-title":"Importance of autoimmune responses in progression of retinal degeneration initiated by gene mutations","volume":"8","author":"Adamus","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/jaut.1998.0221","article-title":"Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cellsin vivo","volume":"11","author":"Adamus","year":"1998","journal-title":"J. Autoimmun."},{"key":"B7","first-page":"283","article-title":"Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy","volume":"38","author":"Adamus","year":"1997","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-4-5","article-title":"Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy","volume":"4","author":"Adamus","year":"2004","journal-title":"BMC Ophthalmol."},{"key":"B9","first-page":"2323","article-title":"Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats","volume":"18","author":"Adamus","year":"2012","journal-title":"Mol. Vis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3928\/23258160-20140131-03","article-title":"The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: A case report and literature review","volume":"45","author":"Ahn","year":"2014","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"B11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0002-9394(86)90766-x","article-title":"Transmission electron microscopic observations of vitreous abnormalities in retinitis pigmentosa","volume":"101","author":"Albert","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"B12","first-page":"3234","article-title":"Inflammatory findings in autosomal recessive retinitis pigmentosa (ARRP) associated with EYS gene mutations","volume":"62","author":"Alekseev","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B13","first-page":"4498","article-title":"Retinal and optic nerve inflammatory findings are a common feature in patients with USH2A-associated retinal degeneration","volume":"63","author":"Alekseev","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/09273940590933511","article-title":"Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema","volume":"13","author":"Androudi","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40123-020-00328-9","article-title":"Bilateral 0.19 mg fluocinolone acetonide intravitreal implant in the successful treatment of juvenile idiopathic arthritis-associated uveitis and secondary macular oedema: A case report and review of intravitreal therapies","volume":"10","author":"Ansari","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.oret.2022.04.018","article-title":"Risk of cystoid macular edema after cataract surgery in retinitis pigmentosa: An analysis of United States claims from 2010 to 2018","volume":"6","author":"Antonio-Aguirre","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/IAE.0b013e31805f6b79","article-title":"Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa","volume":"27","author":"Apushkin","year":"2007","journal-title":"Retina"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1007\/s12325-017-0635-3","article-title":"Update on the treatment of uveitis in patients with juvenile idiopathic arthritis: A review","volume":"34","author":"Asproudis","year":"2017","journal-title":"Adv. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: A systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0002-9394(85)90351-4","article-title":"Natural course of retinitis pigmentosa over a three-year interval","volume":"99","author":"Berson","year":"1985","journal-title":"Am. J. Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.9.11.9","article-title":"The RUSH2A study: Best-corrected visual acuity, full-field electroretinography amplitudes, and full-field Stimulus thresholds at baseline","volume":"9","author":"Birch","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1869-5760-3-61","article-title":"Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: A case report","volume":"3","author":"Bourgault","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"B23","first-page":"743","article-title":"Immune reactivity to different retinal antigens in patients suffering from retinitis pigmentosa","volume":"19","author":"Brinkman","year":"1980","journal-title":"Investigative Ophthalmol. Vis. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00154420","article-title":"Immune responsiveness to retinal S-antigen and opsin in serpiginous choroiditis and other retinal diseases","volume":"69","author":"Broekhuyse","year":"1988","journal-title":"Doc. Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/02713688609020059","article-title":"Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis","volume":"5","author":"Chan","year":"1986","journal-title":"Curr. Eye Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/bjo.69.1.19","article-title":"Autoimmunity in hereditary retinal degeneration. I. Basic studies","volume":"69","author":"Chant","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"895208","DOI":"10.3389\/fmed.2022.895208","article-title":"Management of cystoid macular edema in retinitis pigmentosa: A systematic review and meta-analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Med. (Lausanne)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1177\/11206721221124688","article-title":"Intravitreal fluocinolone acetonide implant for chronic postoperative cystoid macular edema - two years results","volume":"33","author":"Chronopoulos","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1073\/pnas.95.1.328","article-title":"Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man","volume":"95","author":"Cideciyan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B31","volume-title":"Summaries of genes and loci causing retinal diseases (RetNet)","author":"Daiger","year":"2020"},{"key":"B32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ajo.2017.04.019","article-title":"Outcomes in autoimmune retinopathy patients treated with rituximab","volume":"180","author":"Davoudi","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0090-1229(85)90121-7","article-title":"Class II antigen expression and gamma interferon modulation of monocytes and retinal pigment epithelial cells from patients with retinitis pigmentosa","volume":"36","author":"Detrick","year":"1985","journal-title":"Clin. Immunol. Immunopathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0002-9394(86)90949-9","article-title":"Expression of HLA-DR antigen on retinal pigment epithelial cells in retinitis pigmentosa","volume":"101","author":"Detrick","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1055\/a-0590-4546","article-title":"Topical corticosteroids and non-steroidal anti-inflammatory drugs in the therapy of non-infectious uveitis","volume":"235","author":"Doycheva","year":"2018","journal-title":"Klin. Monatsblatter fur Augenheilkd."},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2020.05.024","article-title":"Baseline visual field findings in the RUSH2A study: Associated factors and correlation with other measures of disease severity","volume":"219","author":"Duncan","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"B37","article-title":"Defective mer-tyrosine kinase (mer-TK) function is associated with anti-arrestin and anti-interphotoreceptor retinoid-binding protein (IRBP) autoantibodies (AAbs) in Mer, Axl, Tyro3 -\/- (TAM) mice and in autosomal recessive retinitis pigmentosa (arRP) patients with a null MERTK mutation","volume":"56","author":"Epstein","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B38","volume-title":"Clinical, functional, and imaging characteristics of cancer-associated retinopathy and optic neuropathy","author":"Epstein","year":"2014"},{"key":"B39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/IAE.0000000000001243","article-title":"Resolution of noninfectious uveitic cystoid macular edema with topical difluprednate","volume":"37","author":"Feiler","year":"2017","journal-title":"Retina"},{"key":"B40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archophthalmol.2009.24","article-title":"Management of autoimmune retinopathies with immunosuppression","volume":"127","author":"Ferreyra","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/ICB.0000000000000766","article-title":"Reconstitution of the ellipsoid zone with tocilizumab in autoimmune retinopathy","volume":"14","author":"Finn","year":"2020","journal-title":"Retin. Cases Brief Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00139579","article-title":"Carriers of X-linked recessive retinitis pigmentosa: Investigation by vitreous fluorophotometry","volume":"4","author":"Fishman","year":"1981","journal-title":"Int. Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archopht.1986.01050160101022","article-title":"Blood-retinal barrier function in patients with cone or cone-rod dystrophy","volume":"104","author":"Fishman","year":"1986","journal-title":"Arch. Ophthalmol."},{"key":"B44","first-page":"1958","article-title":"Cystoid macular edema in retinitis pigmentosa: Clinical and functional evaluation of patients treated with deflazacort. [ARVO abstracts]","volume":"35","author":"Forte","year":"1994","journal-title":"Invest. Ophthalmol. VisSci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ajo.2016.05.013","article-title":"Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified delphi approach","volume":"168","author":"Fox","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/jop.2016.0139","article-title":"Single dexamethasone intravitreal implant in the treatment of noninfectious uveitis","volume":"33","author":"Frere","year":"2017","journal-title":"J. ocular Pharmacol. Ther. official J. Assoc. Ocular Pharmacol. Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10633-018-9638-x","article-title":"ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram","volume":"136","author":"Frishman","year":"2018","journal-title":"Doc. Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/ng0795-360","article-title":"A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese","volume":"10","author":"Fuchs","year":"1995","journal-title":"Nat. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"pgac003","DOI":"10.1093\/pnasnexus\/pgac003","article-title":"Circulating inflammatory monocytes oppose microglia and contribute to cone cell death in retinitis pigmentosa","volume":"1","author":"Funatsu","year":"2022","journal-title":"PNAS Nexus"},{"key":"B50","first-page":"4508","article-title":"Emerging phenotypic characteristics and identification of novel mutations in autosomal recessive retinitis pigmentosa (ARRP) associated with the EYS gene","volume":"60","author":"Gattegna","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/archopht.1980.01020030303013","article-title":"X-linked recessive retinitis pigmentosa and vitreous fluorophotometry. A study of female heterozygotes","volume":"98","author":"Gieser","year":"1980","journal-title":"Arch. Ophthalmol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/ICB.0000000000000872","article-title":"Sarilumab for recalcitrant cystoid macular edema in non-paraneoplastic autoimmune retinopathy","volume":"15","author":"Grewal","year":"2021","journal-title":"Retin. Cases Brief Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.5301\/ejo.5000772","article-title":"Multifocal choroiditis with panuveitis in an 8-year-old boy with long-standing idiopathic acute anterior uveitis","volume":"26","author":"Grixti","year":"2016","journal-title":"Eur. J. Ophthalmol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00006982-199705000-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina"},{"key":"B56","first-page":"202","article-title":"Careful clinical-functional phenotyping combined with systematic, broad NGS Panel-based genotyping identify numerous novel disease-causing mutations and deletions in inherited retinal disease patients","volume":"28","author":"Gupta","year":"2022","journal-title":"Mol. Vis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/ICB.0b013e31809ed9db","article-title":"Topical nepafenac 0.1% for treatment of chronic uveitic cystoid macular edema","volume":"2","author":"Hariprasad","year":"2008","journal-title":"Retin Cases Brief. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4274\/tjo.galenos.2019.81594","article-title":"Intravitreal dexamethasone implant in the treatment of non-infectious uveitis","volume":"49","author":"Hasanreisoglu","year":"2019","journal-title":"Turk J. Ophthalmol."},{"key":"B59","first-page":"179","article-title":"Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations","volume":"94","author":"Heckenlively","year":"1996","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00281-008-0114-7","article-title":"Autoimmune retinopathy: A review and summary","volume":"30","author":"Heckenlively","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s0002-9394(98)00446-2","article-title":"Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa","volume":"127","author":"Heckenlively","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-319-75402-4_24","article-title":"Autoimmune retinopathy: An immunologic cellular-driven disorder","volume-title":"Retinal degenerative diseases","author":"Heckenlively","year":"2018"},{"key":"B63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-3-319-75402-4_24","article-title":"Autoimmune retinopathy: An immunologic cellular-driven disorder","volume":"1074","author":"Heckenlively","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/bjo.69.10.758","article-title":"Autoimmunity in hereditary retinal degenerations. II. Clinical studies: Antiretinal antibodies and fluorescein angiogram findings","volume":"69","author":"Heckenlively","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/112067210801800318","article-title":"Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis","volume":"18","author":"Hogewind","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/cells9030630","article-title":"Innate and autoimmunity in the pathogenesis of inherited retinal dystrophy","volume":"9","author":"Hollingsworth","year":"2020","journal-title":"Cells"},{"key":"B67","article-title":"Peptidylarginine deiminase (PAD4) expression and citrullination levels in normal and mouse retinas and in murine models of late (Sod1-\/-) and early-onset (Tyro3-\/-, Axl-\/-, Mertk-\/- or TAM mice) retinal degeneration","volume":"56","author":"Hollingsworth","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1167\/iovs.18-24118","article-title":"Murine retinal citrullination declines with age and is mainly dependent on peptidyl arginine deiminase 4 (PAD4)","volume":"59","author":"Hollingsworth","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B69","article-title":"Peptidylarginine deiminase 4 (PAD4) is the primary mediator of retinal citrullination in mice","volume":"58","author":"Hollingsworth","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"6699103","DOI":"10.1155\/2020\/6699103","article-title":"A review of complicated cataract in retinitis pigmentosa: Pathogenesis and cataract surgery","volume":"2020","author":"Hong","year":"2020","journal-title":"J. Ophthalmol."},{"key":"B71","volume-title":"Recognizing, characterizing, and managing inflammation in inherited retinal degenerations: Treatable, visually impactful complications beyond cystoid macular edema RD2021 Meeting","author":"Iannaccone","year":"2021"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0145323","DOI":"10.1371\/journal.pone.0145323","article-title":"Circulating autoantibodies in age-related macular degeneration recognize human macular tissue antigens implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis","volume":"10","author":"Iannaccone","year":"2015","journal-title":"PLoS ONE"},{"key":"B73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.exer.2016.12.006","article-title":"Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration","volume":"155","author":"Iannaccone","year":"2017","journal-title":"Exp. Eye Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1016\/j.visres.2006.08.018","article-title":"Retinitis pigmentosa associated with rhodopsin mutations: Correlation between phenotypic variability and molecular effects","volume":"46","author":"Iannaccone","year":"2006","journal-title":"Vis. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4614-0631-0_2","article-title":"Autoimmune biomarkers in age-related macular degeneration: A possible role player in disease development and progression","volume":"723","author":"Iannaccone","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-030-27378-1_29","article-title":"Increased protein citrullination as a trigger for resident immune system activation, intraretinal inflammation, and promotion of anti-retinal autoimmunity: Intersecting paths in retinal degenerations of potential therapeutic relevance","volume":"2019","author":"Iannaccone","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01203333","article-title":"Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa","volume":"90","author":"Iannaccone","year":"1995","journal-title":"Doc. Ophthalmol."},{"key":"B78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-0067-4_16","article-title":"Usher syndrome: Correlation between visual field size and maximal ERG response b-wave amplitude","volume-title":"Retinal degenerations: Mechanisms and experimental therapy. Adv exp med biol. 533","author":"Iannaccone","year":"2003"},{"key":"B79","volume-title":"Long-term results of a pilot study on thymopentin in the treatment of retinitis pigmentosa: Pathophysiological considerations [Italian] IV national congress of the Italian association for ocular pharmacology (AISFO)","author":"Iannaccone","year":"1994"},{"key":"B80","first-page":"461","article-title":"Long-term results of a pilot study on thymopentin in the treatment of retintitis pigmentosa: Pathophysiological considerations [Italian]","volume-title":"The IV national congress of the Italian association for ocular pharmacology (AISFO)","author":"Iannaccone","year":"1994"},{"key":"B81","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0014-4835(89)90009-2","article-title":"Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa","volume":"48","author":"Jacobson","year":"1989","journal-title":"Exp. Eye Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1442-9071.2005.00938.x","article-title":"Clinical features and visual outcome of intermediate uveitis in children","volume":"33","author":"Jain","year":"2005","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1517\/14656560903188425","article-title":"Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent","volume":"10","author":"Jones","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"CD010516","DOI":"10.1002\/14651858.CD010516.pub2","article-title":"Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery","volume":"7","author":"Juthani","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e52180","DOI":"10.15252\/embr.202052180","article-title":"Connecting autoimmune disease to Bardet-Biedl syndrome and primary cilia","volume":"22","author":"Kanie","year":"2021","journal-title":"EMBO Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10792-019-01228-z","article-title":"Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors","volume":"40","author":"Karasu","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1073\/pnas.95.6.2824","article-title":"Biochemical evidence for pathogenicity of rhodopsin kinase mutations correlated with the oguchi form of congenital stationary night blindness","volume":"95","author":"Khani","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1097\/IAE.0000000000001406","article-title":"Prospective evaluation of a sustained-release dexamethasone intravitreal implant for cystoid macular edema in quiescent uveitis","volume":"37","author":"Khurana","year":"2017","journal-title":"Retina"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/01.iae.0000254897.86389.a5","article-title":"Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa","volume":"26","author":"Kim","year":"2006","journal-title":"Retina"},{"key":"B90","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1755-3768.2012.02483.x","article-title":"Peripheral multifocal chorioretinitis: Complications, prognosis and relation with sarcoidosis","volume":"91","author":"Koop","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5301\/ejo.5000096","article-title":"Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa","volume":"22","author":"Ksantini","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.10.007","article-title":"Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats","volume":"254","author":"Kyger","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000368052","article-title":"Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome","volume":"233","author":"Lemos Reis","year":"2015","journal-title":"Ophthalmologica"},{"key":"B94","doi-asserted-by":"publisher","first-page":"10146","DOI":"10.1096\/fj.202000282R","article-title":"Pharmacological clearance of misfolded rhodopsin for the treatment of RHO-associated retinitis pigmentosa","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/IAE.0000000000001542","article-title":"Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid macular edema","volume":"38","author":"Mansour","year":"2018","journal-title":"Retina"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archopht.1990.01070130026013","article-title":"Hypothesis concerning carbonic anhydrase treatment of cystoid macular edema: Example with epiretinal membrane","volume":"108","author":"Marmor","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.survophthal.2018.03.002","article-title":"A review of the immunologic findings observed in retinitis pigmentosa","volume":"63","author":"McMurtrey","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"eade9459","DOI":"10.1126\/sciadv.ade9459","article-title":"Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in Mertk-associated retinitis pigmentosa","volume":"9","author":"Mercau","year":"2023","journal-title":"Sci. Adv."},{"key":"B100","doi-asserted-by":"publisher","first-page":"NP23","DOI":"10.1177\/11206721211046718","article-title":"Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes","volume":"33","author":"Miguel-Escuder","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0214639","DOI":"10.1371\/journal.pone.0214639","article-title":"Comparison of the molecular properties of retinitis pigmentosa P23H and N15S amino acid replacements in rhodopsin","volume":"14","author":"Mitchell","year":"2019","journal-title":"PLoS ONE"},{"key":"B102","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/bjo.68.7.489","article-title":"Vitreous fluorophotometry in patients with cone-rod dystrophy","volume":"68","author":"Miyake","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00006982-199701000-00004","article-title":"Oguchi disease: Phenotypic characteristics of patients with the frequent 1147DELA mutation in the arrestin gene","volume":"17","author":"Nakazawa","year":"1997","journal-title":"Retina"},{"key":"B104","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/0002-9394(88)90050-5","article-title":"Detection of lymphocytes in the vitreous gel of patients with retinitis pigmentosa","volume":"105","author":"Newsome","year":"1988","journal-title":"Am. J. Ophthalmol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2022.10.001","article-title":"Outcome of cataract surgery in patients with retinitis pigmentosa","volume":"246","author":"Nguyen","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/ICB.0b013e31825a300f","article-title":"Topical steroidal and nonsteroidal antiinflammatory drugs for the treatment of cystoid macular edema in retinitis pigmentosa","volume":"7","author":"Park","year":"2013","journal-title":"Retin Cases Brief. Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/IAE.0000000000002589","article-title":"A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa","volume":"40","author":"Park","year":"2020","journal-title":"Retina"},{"key":"B108","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/eye.2013.314","article-title":"Coat's-like exudation in rhodopsin retinitis pigmentosa: Successful treatment with an intravitreal dexamethasone implant","volume":"28","author":"Patil","year":"2014","journal-title":"Eye (Lond)."},{"key":"B109","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.4049\/jimmunol.145.12.4101","article-title":"Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation","volume":"145","author":"Percopo","year":"1990","journal-title":"J. Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/14656566.7.1.99","article-title":"An update on the use of ophthalmic ketorolac tromethamine 0.4%","volume":"7","author":"Perry","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"B111","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/09273948.2016.1269931","article-title":"The use of topical non-steroidal anti-inflammatory drugs for uveitic cystoid macular edema","volume":"26","author":"Petrushkin","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"B112","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10792-016-0265-9","article-title":"Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis","volume":"37","author":"Pichi","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"B113","first-page":"235","article-title":"Thymopentin in Retinitis Pigmentosa. Evaluation of its possible therapeutical effects after 18 months of treatment, preliminary results","volume":"6","author":"Rispoli","year":"1991","journal-title":"New Trends Ophthalmol."},{"key":"B114","article-title":"Thymopentin (Timunox) in retinitis pigmentosa: Evaluation of its therapeutical effects after 18 months of treatment. Preliminary results","volume-title":"XXVI international congress of ophthalmology (ICO)","author":"Rispoli","year":"1990"},{"key":"B115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5935\/0004-2749.20150049","article-title":"Treatment of cystoid macular edema secondary to chronic non-infectious intermediate uveitis with an intraocular dexamethasone implant","volume":"78","author":"Rossetto","year":"2015","journal-title":"Arq. Bras. Oftalmol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/meajo.meajo_134_21","article-title":"Bromfenac 0.09% for the treatment of macular edema secondary to noninfectious uveitis","volume":"28","author":"Saade","year":"2021","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"B117","first-page":"1693","article-title":"The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa","volume":"37","author":"Sandberg","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","article-title":"Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide","volume":"34","author":"Saraiva","year":"2003","journal-title":"Ophthalmic Surg. Lasers Imaging"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.jcjo.2015.12.021","article-title":"Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide","volume":"51","author":"Schaal","year":"2016","journal-title":"Can. J. Ophthalmol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajo.2018.03.027","article-title":"Difluprednate for the treatment of uveitic cystoid macular edema","volume":"191","author":"Schallhorn","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00006982-200502000-00011","article-title":"Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation","volume":"25","author":"Schilling","year":"2005","journal-title":"Retina"},{"key":"B122","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/archopht.125.6.759","article-title":"Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone","volume":"125","author":"Scorolli","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"11","author":"Sen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajo.2011.10.008","article-title":"Efficacy and potential complications of difluprednate use for pediatric uveitis","volume":"153","author":"Slabaugh","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00006982-199110000-00008","article-title":"Treatment of cystoid macular edema with acetazolamide in a patient with serpiginous choroidopathy","volume":"11","author":"Steinmetz","year":"1991","journal-title":"Retina"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00417-021-05504-6","article-title":"Intravitreal fluocinolone acetonide 0.19\u00a0mg (Iluvien\u00ae) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients","volume":"260","author":"Studsgaard","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1152\/ajpregu.00243.2022","article-title":"T cell-specific deficiency in BBSome component BBS1 interferes with selective immune responses","volume":"324","author":"Stump","year":"2023","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00417-017-3660-7","article-title":"Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: A pilot study","volume":"255","author":"Sudhalkar","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/eye.1998.168","article-title":"Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis","volume":"12","author":"Tanner","year":"1998","journal-title":"Eye (Lond)."},{"key":"B130","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.survophthal.2004.06.002","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF02133687","article-title":"Vitreous fluorophotometry studies in retinitis pigmentosa","volume":"222","author":"Travassos","year":"1985","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e50785","DOI":"10.15252\/embr.202050785","article-title":"Bardet-Biedl Syndrome ciliopathy is linked to altered hematopoiesis and dysregulated self-tolerance","volume":"22","author":"Tsyklauri","year":"2021","journal-title":"EMBO Rep."},{"key":"B133","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J. ocular Pharmacol. Ther. official J. Assoc. Ocular Pharmacol. Ther."},{"key":"B134","article-title":"Thymopentin in the treatment of retinitis pigmentosa: Results after a three-year follow-up","volume-title":"Retinitis pigmentosa present knowledge and outlook","author":"Vingolo","year":"1993"},{"key":"B135","article-title":"Three-year experience in the treatment of retinitis pigmentosa with thymopentin","volume-title":"4th meeting of the schepens international society","author":"Vingolo","year":"1993"},{"key":"B136","first-page":"1124","article-title":"The photopic negative response of the macaque electroretinogram: Reduction by experimental glaucoma","volume":"40","author":"Viswanathan","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-2000-10561","article-title":"Antiretinale Antik\u00f6rper assoziiert mit zystoidem Makula\u00f6dem1","volume":"216","author":"Wolfensberger","year":"2000","journal-title":"Klin. Monatsblatter fur Augenheilkd."},{"key":"B138","first-page":"3401","article-title":"Membrane-bound carbonic anhydrase in human retinal pigment epithelium","volume":"35","author":"Wolfensberger","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/a:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc. Ophthalmol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/bjophthalmol-2020-315911","article-title":"A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation","volume":"105","author":"Wong","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10792-012-9559-8","article-title":"Intravitreal infliximab for refractory pseudophakic cystoid macular edema: Results of the pan-American collaborative retina study group","volume":"32","author":"Wu","year":"2012","journal-title":"Int. Ophthalmol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e69506","DOI":"10.1371\/journal.pone.0069506","article-title":"Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice","volume":"8","author":"Xiong","year":"2013","journal-title":"PLoS One"},{"key":"B143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0297-175","article-title":"Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness","volume":"15","author":"Yamamoto","year":"1997","journal-title":"Nat. Genet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.61.10.25","article-title":"Suppression of cGMP-dependent photoreceptor cytotoxicity with mycophenolate is neuroprotective in murine models of retinitis pigmentosa","volume":"61","author":"Yang","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1159\/000055501","article-title":"Visual function and gene analysisin a family with oguchi's disease","volume":"30","author":"Yoshii","year":"1998","journal-title":"Ophthalmic Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1177711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T15:43:59Z","timestamp":1681400639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1177711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":145,"alternative-id":["10.3389\/fcell.2023.1177711"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1177711","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"article-number":"1177711"}}